Singlomics - Crunchbase Company Profile & Funding

Q: Where is Singlomics's headquarters?

Singlomics is located in Beijing, Beijing, China.

Q: Who invested in Singlomics?

Singlomics has 13 investors including Tencent And Huagai Capital.

Q: When was the last funding round for Singlomics?

Singlomics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Singlomics raised to date?

Singlomics has raised obfuscated.

Overview

Singlomics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Singlomics

CB Rank

61997

Singlomics uses single-cell sequencing technology for antibody drug discovery.

Founded

obfuscation

Private

Venture - Series Unknown

Beijing, Beijing, China

11-50

www.singlomics.com

Biotechnology

Health Care

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Yunlong Cao: Co-Founder
Xiaoliang Sunney Xie: Co-Founder

Details

Legal Name

Beijing Danxu Biopharmaceutical Co., Ltd.

Also Known As

丹序生物, 北京丹序生物制药有限公司

Operating Status

Active

Company Type

For Profit

Founders

Xiaoliang Sunney Xie, Yunlong Cao

About the Company

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Phone Number

010-80765087

Contact Email

contact@singlomics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Singlomics is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

DXP-604

A human-derived monoclonal antibody targeting SARS-CoV-2, effective against multiple variants including Delta and Omicron, currently in clinical development for COVID-19 treatment and prevention.

DXP-593

A human-derived monoclonal antibody against SARS-CoV-2 with strong neutralizing activity, identified from convalescent patients, previously in clinical trials for COVID-19 treatment.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Singlomics	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Tencent	Yes	Venture Round - Singlomics	—
Tencent	Yes	Venture Round - Singlomics	—
Tencent	Yes	Venture Round - Singlomics	—
Tencent	Yes	Venture Round - Singlomics	—
Tencent	Yes	Venture Round - Singlomics	—